We are live on ! Find out more
THRD

Third Harmonic Bio
THRD

Delisted

THRD was delisted on the 30th of July, 2025.

Back to rankings

40 hedge funds and large institutions have $563M invested in Third Harmonic Bio in 2022 Q3 according to their latest regulatory filings, with 40 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

91.67% more ownership

Funds ownership: 0% → 91.67% (+92%)

Holders
40
Holders Change
+40
Holders Change %
–
% of All Funds
0.69%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
40
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AVLSA
Atlas Venture Life Science Advisors
Massachusetts
+$197M
2
O
OrbiMed
New York
+$104M
3
BI
BVF Inc
California
+$63.1M
4
RCM
RA Capital Management
Massachusetts
+$62.6M
5
GA
General Atlantic
New York
+$53.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
26
Two Sigma Investments
New York
$474K +$451K +25,000 New
Manulife (Manufacturers Life Insurance)
27
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$391K +$374K +20,766 New
PHK
28
Point72 Hong Kong
Hong Kong
$362K +$344K +19,099 New
Jane Street
29
Jane Street
New York
$357K +$339K +18,809 New
PIM
30
Platinum Investment Management
Australia
$338K +$321K +17,825 New
CCM
31
CAAS Capital Management
New York
$304K +$288K +16,000 New
PAMP
32
Polar Asset Management Partners
Ontario, Canada
$220K +$209K +11,596 New
CSS
33
Cubist Systematic Strategies
Connecticut
$200K +$190K +10,561 New
EP
34
Eversept Partners
New York
$190K +$180K +10,000 New
Point72 Asset Management
35
Point72 Asset Management
Connecticut
$152K +$144K +8,000 New
Morgan Stanley
36
Morgan Stanley
New York
$136K +$129K +7,160 New
O
37
OrbiMed
New York
$110K +$104M +5,779,071 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$105K +$100K +5,557 New
UBS Group
39
UBS Group
Switzerland
$24K +$22.6K +1,252 New
SIM
40
Sandia Investment Management
Massachusetts
$19K +$18K +1,000 New
1
2

THRD Hedge Fund Activity: Q3 2022 in Review

40 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Third Harmonic Bio (THRD) for Q3 2022, worth a combined $563M.

Buyers outnumbered sellers: 40 funds opened new THRD positions and 0 closed out — a net gain of 40 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Atlas Venture Life Science Advisors, opening a new position worth an estimated $197M.

  • 40 institutional investors held Third Harmonic Bio (THRD) as of Q3 2022, up from 0 in Q2 2022.
  • Funds reported $563M of Third Harmonic Bio stock for Q3 2022.
  • 40 funds opened new Third Harmonic Bio positions in Q3 2022 and 0 closed out, a net change of +40 holders.
  • The largest Third Harmonic Bio buyer in Q3 2022 was Atlas Venture Life Science Advisors, an estimated $197M added.

Based on aggregated 13F filings for Q3 2022.